CURE Pharmaceutical Receives NSF’s cGMP Certification for Dietary Supplements

GlobeNewswire•July 8, 2020 OXNARD, Calif., July 08, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today announced that its 25,000 square foot manufacturing facility has earned NSF International, cGMP certification for the manufacture of dietary supplements. This certification is issued only after extensive material and facility analysis and gives…

Altum Announces Name Change and Date of AGM

Newsfile Corp –June 30, 2020 Vancouver, British Columbia–(Newsfile Corp. – June 30, 2020) – Altum Resource Corp. (CSE: ALTM) (the “Company” or “Altum”) is pleased to announce that it has changed its corporate name from “Altum Resource Corp.” to “GoldHaven Resources Corp.”. The Company’s name change reflects the Company’s focus on acquiring, exploring and developing…

Altum Reports Results of 16.55 g/t Au, 46.4% Cu and 144 g/t Ag from its 2020 Adam West Exploration Program

Newsfile Corp. NewsfileJune 29, 2020   Vancouver, British Columbia–(Newsfile Corp. – June 29, 2020) – Altum Resource Corp. (CSE: ALTM) (“Altum” or the “Company”) is pleased to report the results from the first phase of its 2020 exploration program on its Adam West property (the “Property”) on northern Vancouver Island. After the positive results from…

CURE Pharmaceutical Appoints Chief Business Officer

GlobeNewswire•June 16, 2020 – Jonathan Berlent Appointed to Newly Created Role – OXNARD, Calif., June 16, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today named Jonathan Berlent, 51, to the newly created position of Chief Business Officer. Mr. Berlent will be responsible for corporate strategy, sourcing and executing…

CURE Pharmaceutical Announces Exercise of Warrants for Cash Proceeds of Approximately $1.4 Million and Completes Earn Out Related to 2019 Acquisition

Published: June 9, 2020 at 12:22 p.m. ET The MarketWatch News Department was not involved in the creation of this content. OXNARD, Jun 09, 2020 (GLOBE NEWSWIRE via COMTEX) — OXNARD, Calif., June 09, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical Holding Corp. (OTC: CURR), an innovative drug delivery company that is developing novel ways to deliver active…

CURE Pharmaceutical Expands to Mexico in Collaboration with Factoria Bogar Subsidiary

GlobeNewswire•June 3, 2020 CURE extends vitamin D, sleep and combination CBD products distribution throughout Mexico OXNARD, Calif., June 03, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, announced today a collaboration with PMI, a subsidiary of Factoria Bogar in Guadalajara, Mexico. PMI will have access to CURE’s innovative drug delivery platform, CUREform™ for its…

Energy Fuels Engages Constantine Karayannopoulos and Brock O’Kelley to Assist in Developing U.S. Rare Earth Element Commercial and Technical Strategies; Presenting at Mining Conference Today

Move Intensifies Energy Fuels’ Effort to Potentially Establish a Commercially Viable Rare Earth Production Capacity in the U.S. that Could Process Multiple Ore Inputs While Recycling Contained Uranium to Generate Fuel for Clean Nuclear Power Plants May 21, 2020 Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels”), the leading producer of uranium in…

Energy Fuels Enters into Agreement to Acquire Prompt Fission Neutron (PFN) Borehole Logging Technology and Equipment; Securing Control over this Critical Technology for U.S. ISR Uranium Production

LAKEWOOD, CO, May 6, 2020 /CNW/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels”), the leading producer of uranium in the United States, is pleased to announce that it has entered into an agreement to acquire from GeoInstruments Logging LLC (“GIL”) all of its Prompt Fission Neutron (“PFN”) technology and equipment, including all of its related…

CURE Pharmaceutical Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions

Equipment manufacturers, cannabis processors and drug developers can license CURE’s patented methods for optimal extraction of cannabinoids LOS ANGELES, April 21, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced the issuance of two U.S. Patents: No. 10,639,339 and 10,624,940. These patents represent an expansion of CURE’s existing “product by…